Clinically feasible MTR is sensitive to cortical demyelination in MS

Neurology

Volumn 80, Issue 3, 2013, Pages 246-252

  Chen, Jacqueline Tien Hsiang ^a,c   Easley, Kathryn ^a   Schneider, Colleen ^a   Nakamura, Kunio ^a   Kidd, Grahame J ^a   Chang, Ansi ^a   Staugaitis, Susan M ^a,b   Fox, Robert J ^a   Fisher, Elizabeth ^a   Arnold, Douglas L ^c   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Laboratory Medicine Institute   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN CORTEX; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAGNETIZATION TRANSFER RATIO IMAGING; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; CADAVER; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEAST-SQUARES ANALYSIS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEOLIPID PROTEIN; REPRODUCIBILITY OF RESULTS;

EID: 84873632038     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827deb99     Document Type: Article

References (22)

1. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-320.
2. Lumsden CE. The neuropathology of multiple sclerosis. In: Winken PJ, Bruyn GW, ed. Handbook of Clinical Neurology. Amsterdam: Elsevier; 1970:174-227.
3. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-732. (Pubitemid 36870458)
4. Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572-577. (Pubitemid 43085960)
5. Simon B, Schmidt S, Lukas C, et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 2010;20:1675-1683.
6. Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012;78:302-308.
7. Seewann A, Vrenken H, Kooi EJ, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011;17:1202-1210.
8. Schmierer K, Parkes HG, So PW, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010;133:858-867.
9. Fisher E, Chang A, Fox RJ, et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann Neurol 2007;62:219-228. (Pubitemid 47525397)
10. Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001;5:143-156. (Pubitemid 35282800)
11. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-285. (Pubitemid 28065253)
12. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging 1998;17:87-97. (Pubitemid 128742012)
13. Codella M, Rocca MA, Colombo B, Martinelli-Boneschi F, Comi G, Filippi M. Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study. J Neurol Sci 2002;194:71-74. (Pubitemid 34051558)
14. De Stefano N, Battaglini M, Stromillo ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006;129:2008-2016. (Pubitemid 44289066)
15. Khaleeli Z, Cercignani M, Audoin B, Ciccarelli O, Miller DH, Thompson AJ. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007;37:253-261. (Pubitemid 47068988)
16. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008;71:632-638.
17. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-2712. (Pubitemid 41552953)
18. Cercignani M, Symms MR, Ron M, Barker GJ. 3D MTR measurement: from 1.5 T to 3.0 T. Neuroimage 2006;31: 181-186. (Pubitemid 43728983)
19. Finelli DA. Magnetization transfer effects on T1-weighted three-dimensional gradient-echo MR images of a phantom simulating enhancing brain lesions. AJNR Am J Neuroradiol 1997;18:147-159.
20. Tofts PS, Steens SC, Cercignani M, et al. Sources of variation in multi-centre brain MTR histogram studies: body-coil transmission eliminates inter-centre differences. MAGMA 2006;19:209-222. (Pubitemid 44438436)
21. Vrenken H, Pouwels PJ, Ropele S, et al. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease. Mult Scler 2007;13:708-716. (Pubitemid 47074092)
22. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-2197.